Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 17 (ZNF17) is a predicted DNA-binding transcription factor belonging to the C2H2-type zinc finger protein family. Like other members of this large and diverse group, ZNF17 is predicted to regulate gene expression by binding specific DNA sequences and modulating RNA polymerase II activity. It contains finger-like structural motifs stabilized by zinc ions and is active in the nucleus. While ZNF17 itself does not have well-characterized roles in human disease, C2H2-type zinc finger proteins as a class play essential functions in transcriptional regulation, cell differentiation, and development and are implicated in numerous cellular processes and diseases
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 17 (ZNF17).